Renal failure is a common accompaniment of multiple myeloma and is usually due to cast nephropathy, or "myeloma kidney." To understand this lesion, four human Bence Jones proteins (BJP) were purified from the urine of volunteers who had either no evidence of renal dysfunction (BJP1) or renal failure from cast nephropathy (BJP2, BJP3, BJP4). When infused directly into the rat nephron in vivo, BJP2, BJP3, and BJP4 produced intraluminal obstruction by precipitating in the distal nephron; protein casts were never identified before the tip of the loop of Henle. Obstruction was related to the concentration of BJP in the perfusate. Addition of furosemide to the perfusate augmented obstruction in a concentration-dependent fashion. Pretreatment of rats with colchicine completely prevented obstruction and cast formation of perfused nephrons; beta-lumicolchicine did not prevent obstruction. Tamm-Horsfall glycoprotein purified from beta-lumicolchicine-treated and untreated rats coaggregated with BJP3 in vitro. Tamm-Horsfall glycoprotein from colchicine-treated rats did not contain sialic acid and did not aggregate with BJP3 in vitro. Thus, cast-forming human BJP coaggregated with Tamm-Horsfall glycoprotein and obstructed the rat distal nephron. Intranephronal obstruction was aggravated by decreasing extracellular fluid volume or adding furosemide. Finally, by decreasing secretion and altering the carbohydrate moiety of Tamm-Horsfall glycoprotein, colchicine prevented intraluminal cast formation and obstruction of the rat nephron.
P W Sanders, B B Booker
Title and authors | Publication | Year |
---|---|---|
Monoclonal gammopathy of renal significance from the perspective of nephrologists.
Park K, Kwon SH |
Blood Research | 2024 |
Widespread amyloidogenicity potential of multiple myeloma patient-derived immunoglobulin light chains.
Sternke-Hoffmann R, Pauly T, Norrild RK, Hansen J, Tucholski F, Høie MH, Marcatili P, Dupré M, Duchateau M, Rey M, Malosse C, Metzger S, Boquoi A, Platten F, Egelhaaf SU, Chamot-Rooke J, Fenk R, Nagel-Steger L, Haas R, Buell AK |
BMC Biology | 2023 |
Multiple myeloma with acute light chain cast nephropathy.
Leung N, Rajkumar SV |
Blood Cancer Journal | 2023 |
High-Cutoff Hemodialysis Therapy for Patients with Light Chain Cast Nephropathy and AKI Requiring Dialysis: CON.
Karakala N, Juncos LA |
2023 | |
Extracorporeal light-chain elimination in myeloma with simple medium cutoff membrane hemodialysis: a retrospective cohort study.
Schaaf CW, Braunisch MC, Holzmann-Littig C, Pfister F, Hannemann L, Hausinger RI, Verbeek M, Schmaderer C, Renders L, Heemann U, Küchle C |
Frontiers in Oncology | 2023 |
Epigenetic roles in clonal hematopoiesis and aging kidney-related chronic kidney disease.
Ogura Y, Mimura I |
Frontiers in Cell and Developmental Biology | 2023 |
How I Treat Light Chain Cast Nephropathy
Pratt G, Pinney JH, Cockwell P |
Clinical journal of the American Society of Nephrology : CJASN | 2023 |
Rhabdomyolysis: an American Association for the Surgery of Trauma Critical Care Committee Clinical Consensus Document.
Kodadek L, Carmichael Ii SP, Seshadri A, Pathak A, Hoth J, Appelbaum R, Michetti CP, Gonzalez RP |
2022 | |
Diagnosis and management of monoclonal gammopathy of clinical significance.
Cho H |
Blood Research | 2022 |
High-cutoff hemodialysis in multiple myeloma patients with acute kidney injury.
Xing Y, Yan J, Yu Z, Zhao J, Wang Y, Li X, Qin Y, Sun S |
Frontiers in Oncology | 2022 |
Management of acute kidney injury in symptomatic multiple myeloma
F Bridoux, N Leung, M Belmouaz, V Royal, P Ronco, SH Nasr, JP Fermand |
Kidney International | 2021 |
The Clone Wars: Diagnosing and Treating Dysproteinemic Kidney Disease in the Modern Era
RS Avasare, NK Andeen, A Havasi, JJ Hogan |
Journal of Clinical Medicine | 2021 |
Kidney injury and disease in patients with haematological malignancies
F Bridoux, P Cockwell, I Glezerman, V Gutgarts, JJ Hogan, KD Jhaveri, F Joly, SH Nasr, D Sawinski, N Leung |
Nature Reviews Nephrology | 2021 |
Management of Bone Disease and Kidney Failure in Multiple Myeloma: A Pocket Guide
E Zamagni |
2021 | |
Acute Kidney Injury in Monoclonal Gammopathies
P Menè, A Moioli, A Stoppacciaro, S Lai, F Festuccia |
Journal of Clinical Medicine | 2021 |
De Novo Sequencing of Antibody Light Chain Proteoforms from Patients with Multiple Myeloma
M Dupré, M Duchateau, R Sternke-Hoffmann, A Boquoi, C Malosse, R Fenk, R Haas, AK Buell, M Rey, J Chamot-Rooke |
Analytical Chemistry | 2021 |
Serum free light chain level at diagnosis in myeloma cast nephropathy—a multicentre study
P Yadav, IJ Sathick, N Leung, EE Brown, M Cook, PW Sanders, P Cockwell |
Blood Cancer Journal | 2020 |
Hemodiafiltration with ultrafiltrate regeneration reduces free light chains without albumin loss in multiple myeloma patients
MV de Mier, R Ojeda, MA Álvarez-Lara, A Navas, C Alonso, J Caballero-Villarraso, P Aljama, MA Álvarez, S Soriano, M Rodríguez, A Martín-Malo |
BMC Nephrology | 2020 |
Biochemical and biophysical characterisation of immunoglobulin free light chains derived from an initially unbiased population of patients with light chain disease
R Sternke-Hoffmann, A Boquoi, DL Niedenhoff, F Platten, R Fenk, R Haas, AK Buell |
PeerJ | 2020 |
Monoclonal Gammopathies of Renal Significance: Renal Biopsy and Beyond
P Menè, LD Alexandris, A Moioli, S Raffa, A Stoppacciaro |
Cancers | 2020 |
Uromodulin and kidneys
M Khasun, SA Orlova, IG Kayukov, OV Galkina, ON Beresneva, MM Parastaeva, AG Kucher, NV Mosina |
2020 | |
Onconephrology: The intersections between the kidney and cancer
MH Rosner, KD Jhaveri, BA McMahon, MA Perazella |
CA: a cancer journal for clinicians | 2020 |
Fatal renal diseases among patients with hematological malignancies: A population‐based study
S Li, K Yu, Y Chen, W Luo, Y Zheng, Y Yang, X Yang, , X Gao, X Wang, B Wu |
2020 | |
Predictive factors of outcome in cervical dystonia following deep brain stimulation: an individual patient data meta-analysis
X Hua, B Zhang, Z Zheng, H Fan, L Luo, X Chen, J Duan, D Zhou, M Li, T Hong, G Lu |
Journal of Neurology | 2020 |
Fatal renal diseases among patients with hematological malignancies: A population-based study.
Li S, Yu K, Chen Y, Luo W, Zheng Y, Yang Y, Yang X, Wang X, Gao X, Wang X, Wu B |
2020 | |
The Role of Volume Regulation and Thermoregulation in AKI during Marathon Running
SG Mansour, TG Martin, W Obeid, RW Pata, KM Myrick, L Kukova, Y Jia, P Bjornstad, JM El-Khoury, CR Parikh |
Clinical journal of the American Society of Nephrology : CJASN | 2019 |
Activin A: a novel urinary biomarker of renal impairment in multiple myeloma
H Iriuchishima, A Maeshima, S Takahashi, T Ishizaki, A Yokohama, N Tsukamoto, T Saitoh, H Murakami, H Handa |
Bioscience Reports | 2019 |
Acute kidney injury in the patient with cancer
MH Rosner, MA Perazella |
Kidney Research and Clinical Practice | 2019 |
A rare case of crystalglobulinemia
B Prasad, R Chibbar, S Muhammad, S Sethi |
2019 | |
CLINICAL IMPORTANCE OF RENAL RECOVER ON OUTCOMES OF NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS WITH SEVERE AND DIALYSIS-DEPENDENT KIDNEY FAILURE
SV Semochkin, EI Zhelnova, EN Misyurina, DS Maryin, AI Ushakova, EA Karimova, EA Baryakh, TN Tolstykh, ES Mavrina, EV Yurova, AV Cherkasova, EY Grishina, DE Gagloeva, KV Yatskov, ON Kotenko, MA Lysenko |
2019 | |
Animal models of monoclonal immunoglobulin-related renal diseases
C Sirac, GA Herrera, PW Sanders, V Batuman, S Bender, MV Ayala, V Javaugue, J Teng, EA Turbat-Herrera, M Cogné, G Touchard, N Leung, F Bridoux |
Nature Reviews Nephrology | 2018 |
Myeloma light chain cast nephropathy, a review
IJ Sathick, ME Drosou, N Leung |
Journal of Nephrology | 2018 |
Light Chain Cast Nephropathy: Practical Considerations in the Management of Myeloma Kidney—What We Know and What the Future May Hold
S Manohar, SH Nasr, N Leung |
Current Hematologic Malignancy Reports | 2018 |
Dystonia
B Balint, NE Mencacci, EM Valente, A Pisani, J Rothwell, J Jankovic, M Vidailhet, KP Bhatia |
Nature Reviews Disease Primers | 2018 |
Serum free light chain levels and renal function at diagnosis in patients with multiple myeloma
P Yadav, P Cockwell, M Cook, J Pinney, H Giles, YS Aung, D Cairns, RG Owen, FE Davies, GH Jackson, JA Child, GJ Morgan, MT Drayson |
BMC Nephrology | 2018 |
A novel biomarker of laminin turnover is associated with disease progression and mortality in chronic kidney disease
SH Nielsen, DG Rasmussen, S Brix, A Fenton, M Jesky, CJ Ferro, M Karsdal, F Genovese, P Cockwell, AI Aguilera |
PloS one | 2018 |
κ Light-chain monoclonal gammopathy and cast nephropathy in a horse with multiple myeloma
C Eberhardt, A Malbon, B Riond, A Schoster |
Journal of the American Veterinary Medical Association | 2018 |
Uromodulin: from physiology to rare and complex kidney disorders
O Devuyst, E Olinger, L Rampoldi |
Nature Reviews Nephrology | 2017 |
Bicarbonate : de la physiologie aux applications thérapeutiques pour tout clinicien
J Beaume, A Braconnier, T Dolley-Hitze, JP Bertocchio |
Néphrologie & Thérapeutique | 2017 |
Insuffisance rénale aiguë obstructive : une lecture physiopathologique
JP Haymann, C Vinsonneau, A Girshovich, M Daudon |
Néphrologie & Thérapeutique | 2017 |
Acute Kidney Injury in Patients with Cancer
JR Ingelfinger, MH Rosner, MA Perazella |
New England Journal of Medicine | 2017 |
The Scope of Kidney Affection in Monoclonal Gammopathies at All Levels of Clinical Significance
ŞM Ünlü, H Özsan, S Sarıoğlu |
Turkish Journal of Hematology | 2017 |
Dysproteinemias and Glomerular Disease
N Leung, ME Drosou, SH Nasr |
Clinical journal of the American Society of Nephrology : CJASN | 2017 |
Neoplastic Diseases of the Blood
PH Wiernik, JP Dutcher, MA Gertz |
2017 | |
My Patient with Monoclonal Gammopathy of Undetermined Significance has a Kidney Problem
N Leung |
2017 | |
AKI in Multiple Myeloma: Paraproteins, Metabolic Disturbances, and Drug Toxicity
M Shah, MA Perazella |
2017 | |
Paraprotein-Related Kidney Disease: Kidney Injury from Paraproteins--What Determines the Site of Injury?
M Doshi, A Lahoti, FR Danesh, V Batuman, PW Sanders |
Clinical journal of the American Society of Nephrology : CJASN | 2016 |
Non-Secretory Myeloma, Diagnosed on Renal Biopsy as Cast Nephropathy
S Grover |
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH | 2016 |
International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment
MA Dimopoulos, P Sonneveld, N Leung, G Merlini, H Ludwig, E Kastritis, H Goldschmidt, D Joshua, RZ Orlowski, R Powles, DH Vesole, L Garderet, H Einsele, A Palumbo, M Cavo, PG Richardson, P Moreau, JS Miguel, SV Rajkumar, BG Durie, E Terpos |
Journal of Clinical Oncology | 2016 |
Plasma Cell Neoplasms
RB Lorsbach, M Yared |
2016 | |
Circulating Monoclonal Light Chains and Acute Kidney Injury: The Role of the Renal Biopsy with Emphasis on Ultrastructural Evaluation in Assessing and Understanding Renal Injury
J Aufman, GA Herrera |
Ultrastructural Pathology | 2015 |
High incidence of intact immunoglobulin or fragments thereof in urine of patients with multiple myeloma
M Kraj, B Kruk, E Lech-Marańda, K Warzocha, M Prochorec-Sobieszek |
Leukemia & Lymphoma | 2015 |
New aspects on the pathogenesis of renal disorders related to monoclonal gammopathies
S Kapoulas, V Raptis, M Papaioanou |
Néphrologie & Thérapeutique | 2015 |
Renal Consequences of Lymphoproliferative Disorders and Monoclonal Gammopathy
EV Zakharova |
2015 | |
Onconephrology
KD Jhaveri, AK Salahudeen |
2015 | |
Pathogenesis of Renal Failure in Multiple Myeloma: Any Role of Contrast Media?
M Mussap, G Merlini |
BioMed Research International | 2014 |
Renal disease in cancer patients
JR Angelo, JA Samuels |
Renal disease in cancer patients | 2014 |
Case report on renal failure reversal in lambda chain multiple myeloma with bortezomib and dexamethasone
BK Patibandla, A Narra, AA Alwassia, A Bartley, GS Sandhu, J Rooney, RM Black |
Case Reports in Nephrology | 2014 |
Clearance of Drugs for Multiple Myeloma Therapy During In Vitro High-Cutoff Hemodialysis: Thoughts and Progress
DH Krieter, E Devine, C Wanner, M Storr, B Krause, HD Lemke |
Artificial Organs | 2014 |
Manifestations rénales au cours du myélome
N Bennani-Guebessi, C Ahomadegbe, S Zamiati |
Journal Africain du Cancer / African Journal of Cancer | 2014 |
Exploring the Relationship Between Serum and Urinary Free Light Chain Levels During the Different Phases of Renal Damage in Multiple Myeloma Patients
ZL Xu, C Wu, WH Teng, K Wan, WJ Jia, HJ Li, L Meng, JF Zhou, Y Tang |
Indian Journal of Hematology and Blood Transfusion | 2014 |
Multiple myeloma
GR Mehta, F Suhail, RY Haddad, G Zalzaleh, EV Lerma |
Disease-a-Month | 2014 |
Renal thrombotic microangiopathy and podocytopathy associated with the use of carfilzomib in a patient with multiple myeloma
L Hobeika, SE Self, JC Velez |
BMC Nephrology | 2014 |
Predictors of Positive Immunofixation Testing in Patients With Acute Kidney Injury:
J Mattana, V Govindappa, A Adamidis, N Kohn |
The American Journal of the Medical Sciences | 2013 |
Current treatments for renal failure due to multiple myeloma
E Kastritis, E Terpos, MA Dimopoulos |
Expert Opinion on Pharmacotherapy | 2013 |
Tubulopathie myélomateuse : l’espoir d’un nouveau médicament
SA el Haj, A Hertig |
Néphrologie & Thérapeutique | 2013 |
Mechanism and Prevention of Acute Kidney Injury from Cast Nephropathy in a Rodent Model
Wei-Zhong Ying, Christopher Allen, Lisa Curtis, Kristal Aaron, Paul W. Sanders |
Journal of Clinical Investigation | 2012 |
Treating myeloma cast nephropathy without treating the myeloma
Nelson Leung |
Journal of Clinical Investigation | 2012 |
Uromodulin in Kidney Injury: An Instigator, Bystander, or Protector?
TM El-Achkar, XR Wu |
American Journal of Kidney Diseases | 2012 |
Novel approaches for reducing free light chains in patients with myeloma kidney
CA Hutchison, J Bladé, P Cockwell, M Cook, M Drayson, JP Fermand, E Kastritis, R Kyle, N Leung, S Pasquali, C Winearls |
Nature Reviews Nephrology | 2012 |
Screening and Differential Diagnosis of Renal Light Chain-Associated Diseases
J Gerth, A Sachse, M Busch, N Illner, LO Muegge, HJ Gröne, G Wolf |
Kidney & blood pressure research | 2012 |
Immunoglobulin free light chain levels and recovery from myeloma kidney on treatment with chemotherapy and high cut-off haemodialysis
CA Hutchison, N Heyne, P Airia, R Schindler, D Zickler, M Cook, P Cockwell, D Grima |
Nephrology Dialysis Transplantation | 2012 |
Dysproteinemias or light chain diseases
AB Irish, R Sinniah |
Nephrology Secrets | 2012 |
Successful Treatment of Patients With Multiple Myeloma and Impaired Renal Function With Lenalidomide: Results of 4 German Centers
K Oehrlein, C Langer, I Sturm, W Pönisch, C Hahn-Ast, S Kuhn, KC Weisel |
Clinical Lymphoma Myeloma & Leukemia | 2012 |
Optimizing Treatment Strategies in Myeloma Cast Nephropathy: Rationale for a Randomized Prospective Trial
F Bridoux, JP Fermand |
Advances in Chronic Kidney Disease | 2012 |
The Pathogenesis of Acute Kidney Impairment in Patients With Multiple Myeloma
V Batuman |
Advances in Chronic Kidney Disease | 2012 |
Current Approach to Diagnosis and Management of Acute Renal Failure in Myeloma Patients
N Leung, J Behrens |
Advances in Chronic Kidney Disease | 2012 |
Myeloma Kidney: Improving Clinical Outcomes?
R Haynes, N Leung, R Kyle, CG Winearls |
Advances in Chronic Kidney Disease | 2012 |
Uremic Toxins: Niwa/Uremic Toxins
S Eloot, G Glorieux, PP de Deyn, R Vanholder |
Uremic Toxins: Niwa/Uremic Toxins | 2012 |
Casting out myeloma kidney
L Osherovich |
Science-Business eXchange | 2012 |
Myeloma kidney: advances in molecular mechanisms of acute kidney injury open novel therapeutic opportunities
A Davenport, G Merlini |
Nephrology Dialysis Transplantation | 2012 |
Diagnostic accuracy of monoclonal antibody based serum immunoglobulin free light chain immunoassays in myeloma cast nephropathy
CA Hutchison, P Cockwell, M Cook |
BMC clinical pathology | 2012 |
Nephrology Secrets
S Hou |
Nephrology Secrets | 2012 |
The biology of immunoglobulin free light chains and kidney injury
K Basnayake, SJ Stringer, CA Hutchison, P Cockwell |
Kidney International | 2011 |
Online high-efficiency haemodiafiltration achieves higher serum free light chain removal than high-flux haemodialysis in multiple myeloma patients: Preliminary Quantitative Study
AG Vallee, L Chenine, H Leray-Moragues, L Patrier, C Cognot, G Cartron, JP Cristol, B Canaud |
Nephrology Dialysis Transplantation | 2011 |
Renal Disease in Hematological Malignancies
IS Abdul-Rahman |
Hong Kong Journal of Nephrology | 2011 |
High Cut-off Dialysis Membranes: Current Uses and Future Potential
B Gondouin, CA Hutchison |
Advances in Chronic Kidney Disease | 2011 |
Renal outcome and monoclonal immunoglobulin deposition disease in 289 old patients with blood cell dyscrasias: A single center experience
P Stratta, L Gravellone, T Cena, D Rossi, GL Gaidano, R Fenoglio, E Lazzarich, M Quaglia, A Airoldi, C Bozzola, G Monga, G Valente, C Canavese, C Magnani |
Critical Reviews in Oncology/Hematology | 2011 |
Extracorporeal Treatment of Cast Nephropathy
B Gakhar, S Kobrin, JS Berns |
Seminars in Dialysis | 2011 |
The pathogenesis and diagnosis of acute kidney injury in multiple myeloma
CA Hutchison, V Batuman, J Behrens, F Bridoux, C Sirac, A Dispenzieri, GA Herrera, H Lachmann, PW Sanders |
Nature Reviews Nephrology | 2011 |
Actualités dans le traitement du myélome avec insuffisance rénale
É Moumas, W Hanf, E Desport, J Abraham, S Delbès, C Debiais, L Lacotte-Thierry, G Touchard, A Jaccard, JP Fermand, F Bridoux |
Néphrologie & Thérapeutique | 2011 |
Pivotal role of apoptosis signal-regulating kinase 1 in monoclonal free light chain-mediated apoptosis
WZ Ying, PX Wang, PW Sanders |
The American Journal of Pathology | 2011 |
Multiple myeloma presenting as acute renal failure
VC Kuo, AZ Fenves, AN Mehta |
Proceedings (Baylor University. Medical Center) | 2011 |
Role of plasmapheresis in the management of myeloma kidney: A systematic review
D GUPTA, L BACHEGOWDA, G PHADKE, S BOREN, D JOHNSON, M MISRA |
Hemodialysis International | 2010 |
Management options for cast nephropathy in multiple myeloma
P Cockwell, CA Hutchison |
Current Opinion in Nephrology and Hypertension | 2010 |
Immunoglobulin Light Chains Activate Tubular Epithelial Cells through Redox Signaling
K Basnayake, WZ Ying, PX Wang, PW Sanders |
Journal of the American Society of Nephrology : JASN | 2010 |
Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis
CA Hutchison, AR Bradwell, M Cook, K Basnayake, S Basu, S Harding, J Hattersley, ND Evans, MJ Chappel, P Sampson, L Foggensteiner, D Adu, P Cockwell |
Clinical journal of the American Society of Nephrology : CJASN | 2009 |
Tamm-Horsfall protein protects the kidney from ischemic injury by decreasing inflammation and altering TLR4 expression
TM El-Achkar, XR Wu, M Rauchman, R McCracken, S Kiefer, PC Dagher |
AJP Renal Physiology | 2008 |
Approach to acute renal failure in biopsy proven myeloma cast nephropathy: Is there still a role for plasmapheresis?
L Pillon, RS Sweeting, A Arora, A Notkin, HS Ballard, RL Wieczorek, N Leung |
Kidney International | 2008 |
Pathogenesis and treatment of renal failure in multiple myeloma
MA Dimopoulos, E Kastritis, L Rosinol, J Bladé, H Ludwig |
Leukemia | 2008 |
A phase I clinical trial of the histone deacetylase inhibitor belinostat in patients with advanced hematological neoplasia
P Gimsing, M Hansen, LM Knudsen, P Knoblauch, IJ Christensen, CE Ooi, P Buhl-Jensen |
European Journal of Haematology | 2008 |
Serum Free-Light Chain Removal by High Cutoff Hemodialysis: Optimizing Removal and Supportive Care
CA Hutchison, S Harding, G Mead, H Goehl, M Storr, A Bradwell, P Cockwell |
Artificial Organs | 2008 |
Effect of methionine oxidation on the structural properties, conformational stability, and aggregation of immunoglobulin light chain LEN
D Hu, Z Qin, B Xue, AL Fink, VN Uversky |
Biochemistry | 2008 |
Therapy in Nephrology & Hypertension
DH Ellison, CS Wilcox |
Therapy in Nephrology & Hypertension | 2008 |
Quantitative Assessment of Serum and Urinary Polyclonal Free Light Chains in Patients with Chronic Kidney Disease
CA Hutchison, S Harding, P Hewins, GP Mead, J Townsend, AR Bradwell, P Cockwell |
Clinical journal of the American Society of Nephrology : CJASN | 2008 |
Resolution of cast nephropathy following free light chain removal by haemodialysis in a patient with multiple myeloma: a case report
K Basnayake, C Hutchison, D Kamel, M Sheaff, N Ashman, M Cook, H Oakervee, A Bradwell, P Cockwell |
Journal of medical case reports | 2008 |
Obstructive Protein Cast Nephropathy in Cynomolgus Monkeys Treated with Small Organic Molecules
RE Guzman, K Datta, NK Khan |
Veterinary pathology | 2008 |
Myeloma Therapy
S Lonial |
2008 | |
Where disease pathogenesis meets protein formulation: Renal deposition of immunoglobulin aggregates
B Demeule, R Gurny, T Arvinte |
European Journal of Pharmaceutics and Biopharmaceutics | 2006 |
Dangerous small B-cell clones
G Merlini, MJ Stone |
Blood | 2006 |
A new twist in myeloma treatment
PW Sanders |
Blood | 2006 |
Management of paraproteinemic renal disease
PW Sanders |
Current Opinion in Nephrology and Hypertension | 2005 |
Management of paraproteinemic renal disease:
PW Sanders |
Current Opinion in Nephrology and Hypertension | 2005 |
Biology and Management of Multiple Myeloma
JR Berenson |
2004 | |
Tamm-Horsfall glycoprotein: biology and clinical relevance
F Serafini-Cessi, N Malagolini, D Cavallone |
American Journal of Kidney Diseases | 2003 |
Monoclonal Gammopathies and the Kidney
G Touchard, P Aucouturier, O Hermine, P Ronco |
2003 | |
Endocytosis of light chains induces cytokines through activation of NF-κB in human proximal tubule cells
S Sengul, C Zwizinski, EE Simon, A Kapasi, PC Singhal, V Batuman |
Kidney International | 2002 |
Urinary proteins and renal dysfunction in patients with multiple myeloma
A Corso, P Zappasodi, M Lazzarino |
Biomedicine & Pharmacotherapy | 2002 |
Mapping the Binding Domain of Immunoglobulin Light Chains for Tamm-Horsfall Protein
WZ Ying, PW Sanders |
The American Journal of Pathology | 2001 |
MALIGNANCY AND RENAL DISEASE
M Kapoor, GZ Chan |
Critical Care Clinics | 2001 |
Management of Renal Complications in Patients with Advanced Multiple Myeloma
A Viertel, E Weidmann, T Ditting, H Geiger |
Leukemia & Lymphoma | 2000 |
RENAL INVOLVEMENT IN MULTIPLE MYELOMA: A 10-YEAR STUDY
V Sakhuja, V Jha, S Varma, K Joshi, KL Gupta, K Sud, HS Kohli |
Renal Failure | 2000 |
Renal manifestations of plasma cell dyscrasias: An appraisal from the patients' bedside to the research laboratory
GA Herrera |
Annals of Diagnostic Pathology | 2000 |
Cytotoxicity of myeloma light chains in cultured human kidney proximal tubule cells
A Pote, C Zwizinski, EE Simon, S Meleg-Smith, V Batuman |
American Journal of Kidney Diseases | 2000 |
Bence Jones-Proteine. Bence Jones Proteins
F Boege |
LaboratoriumsMedizin | 1999 |
A middle-aged woman with refractory graft dysfunction in the early posttransplant period
X Geiger, D Harris, DV Buren, S Goral, JH Helderman, A Fogo |
American Journal of Kidney Diseases | 1999 |
Dietary salt regulates expression of Tamm-Horsfall glycoprotein in rats
WZ Ying, PW Sanders |
Kidney International | 1998 |
In vitro modulation of AL-amyloid formation by human mesangial cells exposed to amyloidogenic light chains
J Isaac, JD Kerby, WJ Russell, SC Dempsey, PW Sanders, GA Herrera |
Amyloid | 1998 |
Multiple Myeloma Presenting with Crystal Deposition in the Bone Marrow
SA Fadilah, SK Cheong |
Hematology | 1998 |
Critical Care Nephrology
C Ronco, R Bellomo |
1998 | |
Localization of a single binding site for immunoglobulin light chains on human Tamm-Horsfall glycoprotein
ZQ Huang, PW Sanders |
Journal of Clinical Investigation | 1997 |
Multiple Myeloma
R Bataille, JL Harousseau |
New England Journal of Medicine | 1997 |
BIOLOGY AND THERAPY OF IMMUNOGLOBULIN DEPOSITION DISEASES
MV Dhodapkar, G Merlini, A Solomon |
Hematology/Oncology Clinics of North America | 1997 |
Differential glycosylation of Bence Jones protein and kidney impairment in patients with plasma cell dyscrasia
T Kagimoto, H Nakakuma, H Hata, M Hidaka, K Horikawa, T Kawaguti, S Nagakura, N Iwamoto, K Shirono, F Kawano, K Takatsuki |
Journal of Laboratory and Clinical Medicine | 1997 |
The renal and hepatic distribution of Bence Jones proteins depends on glycosylation: a scintigraphic study in rats
MJ Prado, AL Nicastri, PL Costa, T Rockman, IL Tersariol, HB Nader, RT Barros, EB Prado |
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas / Sociedade Brasileira de Biofisica ... [et al.] | 1997 |
Protein and host factors implicated in the pathogenesis of light chain amyloidosis (AL amyloidosis)
A Solomon, DT Weiss |
Amyloid | 1995 |
Acute myeloma kidney
CG Winearls |
Kidney International | 1995 |
Protease resistance and binding of Ig light chains in myeloma-associated tubulopathies
M Leboulleux, B Lelongt, B Mougenot, G Touchard, R Makdassi, A Rocca, LH Noel, PM Ronco, P Aucouturier |
Kidney International | 1995 |
Use of a renal tubule cell line (LLC-PK1) to study the nephrotoxic potential of a kappa-type bence-jones protein
MC Diemert, V Tricottet, L Benel, G Descamps, E Escolano, J Galli, M Reynès, F Rousselet |
In vitro cellular & developmental biology. Animal | 1995 |
Ultrastructural Immunolabeling: A Unique Diagnostic Tool in Monoclonal Light Chain-Related Renal Diseases
GA Herrera, PW Sanders, BV Reddy, JA Hasbargen, WS Hammond, JD Brooke |
Ultrastructural Pathology | 1994 |
Nephrotoxic Risks of Renal Angiography: Contrast MediaAssociated Nephrotoxicity and Atheroembolism—A Critical Review
MR Rudnick, JS Berns, RM Cohen, S Goldfarb |
American Journal of Kidney Diseases | 1994 |
Electrophoretic study of the physico-chemical characteristics of Bence-Jones proteinuria and its association with kidney damage
MC Diemert, L Musset, O Gaillard, S Escolano, A Baumelou, F Rousselet, J Galli |
Journal of clinical pathology | 1994 |
Bence Jones proteins bind to a common peptide segment of Tamm-Horsfall glycoprotein to promote heterotypic aggregation
ZQ Huang, KA Kirk, KG Connelly, PW Sanders |
Journal of Clinical Investigation | 1993 |
Tamm-Horsfall glycoprotein binds IgG with high affinity
DC Rhodes, EJ Hinsman, JA Rhodes |
Kidney International | 1993 |
Renale Verlaufsformen der Bence-Jones Proteinurie
F Boege, M Merkle, R Homeyer, F Gieseler |
LaboratoriumsMedizin | 1993 |
Systemic lambda light-chain deposition presenting with predominant cardiac involvement
MJ Garton, S Walton, SW Ewen |
Postgraduate medical journal | 1993 |
Mechanisms in B-Cell Neoplasia 1992
M Potter, F Melchers |
1992 | |
High-Resolution Electrophoresis and Immunofixation
DF Keren |
High-Resolution Electrophoresis and Immunofixation | 1987 |